key: cord-0915392-80l40kir authors: Deng, Junwen; Ngo, Tracy; Zhu, Tian Hao; Halverstam, Caroline title: Telogen Effluvium, Beau’s Lines, and Acral Peeling Associated with COVID-19 Infection date: 2021-06-06 journal: JAAD Case Rep DOI: 10.1016/j.jdcr.2021.05.026 sha: 2091365d1d386b2e55c0ccf2d4d9bfe429def568 doc_id: 915392 cord_uid: 80l40kir nan The management of our patient involved addressing the underlying cause, which in the 115 case of her COVID-19 illness, was self-limited. As telogen effluvium and Beau's lines may take 116 6-12 months to completely resolve, it is important to inform the patient that these cutaneous 117 changes will eventually improve and baseline appearances will be restored. 5 Since cutaneous 118 manifestations may be the only presenting symptom in 12% of COVID-19 patients, continued 119 research is warranted to completely characterize the spectrum of COVID-19 cutaneous 120 manifestations. 2 121 J o u r n a l P r e -p r o o f COVID-19: Insight into the asymptomatic SARS-124 Diagnostic value of cutaneous manifestation of 126 SARS-CoV-2 infection Cutaneous Manifestations of COVID-19: A 129 Systematic Review COVID-131 19 and multisystem inflammatory syndrome in children and adolescents Telogen Effluvium: A Review Telogen effluvium associated 135 with COVID-19 infection Peeling Skin Disorders: A Paradigm for Skin Desquamation Beau's Lines and Leukonychia in a COVID-19 COVID-141 19 and multiorgan failure: A narrative review on potential mechanisms Current 144 Overview on Hypercoagulability in COVID-19 Impact of liver 147 enzymes on SARS-CoV-2 infection and the severity of clinical course of COVID-148 19